Open AccessMiddle Eastern Respiratory Syndrome Corona Virus (MERS CoV): case reports from a tertiary care hospital in Saudi Arabia
Author(s) -
Mohammad Khalid,
Behram Khan,
Fahad Al Rabiah,
Ruwaida Alismaili,
Sarfraz Saleemi,
Agha Muhammad Rehan-Khaliq,
Ihab Weheba,
Hail Al Abdely,
Magid Halim,
Quaid Nadri,
Abdullah Mohsin Al Dalaan,
Mohamed Zeitouni,
Taimur Butt,
Eid Al Mutairy
Publication year - 2014
Publication title -
annals of saudi medicine/annals of saudi medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.373
H-Index - 44
eISSN - 0975-4466
pISSN - 0256-4947
DOI - 10.5144/0256-4947.2014.396
Subject(s) - medicine , covid-19 , library science , classics , history , pathology , computer science , disease , infectious disease (medical specialty)
Middle Eastern respiratory syndrome caused by novel coronavirus (MERS CoV) has been a major public health challenge since it was first described in 2012 in Saudi Arabia. So far, there is no effective treatment for this serious illness, which features a high mortality rate. We report an initial experience of the use of ribavirin and interferon (IFN)-a2b in the management of MERS CoV at a tertiary care hospital.